Rosy Eloy

ADO09, a co‐formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetes

G. Meiffren, T. Heise, J. DeVries, 2020, Diabetes, obesity & metabolism.

Glucagon- and glicentin-immunoreactive cells in the human digestive tract

C. Stock, A. Moody, R. Eloy, 2004, Cell and Tissue Research.

Jejunal Factor Stimulating Insulin Release in the Isolated Perfused Canine Pancreas and Jejunum*

D. Jaeck, A. Moody, R. Eloy, 1975, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

A co‐formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes

G. Meiffren, T. Heise, M. Riddle, 2023, Diabetes, obesity and metabolism.

Chick embryo pancreatic transplants reverse experimental diabetes of rats.

M. Kedinger, R. Eloy, Rosy Eloy, 1979, The Journal of clinical investigation.

ADO09, a co-formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes.

M. Gaudier, C. Mégret, G. Andersen, 2024, Diabetes, obesity & metabolism.